| Primary |
| Crohn's Disease |
26.8% |
| Rheumatoid Arthritis |
23.7% |
| Inflammatory Bowel Disease |
8.5% |
| Colitis Ulcerative |
7.6% |
| Drug Use For Unknown Indication |
7.3% |
| Psoriasis |
5.4% |
| Premedication |
3.4% |
| Psoriatic Arthropathy |
2.6% |
| Ankylosing Spondylitis |
2.5% |
| Drug Exposure During Pregnancy |
1.9% |
| Hypertension |
1.6% |
| Ill-defined Disorder |
1.4% |
| Juvenile Arthritis |
1.4% |
| Product Used For Unknown Indication |
1.4% |
| Prophylaxis |
1.2% |
| Pustular Psoriasis |
0.9% |
| Chronic Obstructive Pulmonary Disease |
0.8% |
| Graft Versus Host Disease |
0.6% |
| Depression |
0.6% |
| Hepatitis C |
0.5% |
|
| Skin Cancer |
22.2% |
| Neoplasm Malignant |
14.7% |
| Liver Disorder |
9.7% |
| Crohn's Disease |
8.7% |
| Breast Cancer |
5.4% |
| Colitis Ulcerative |
5.0% |
| Lupus-like Syndrome |
4.0% |
| Tuberculosis |
3.8% |
| Pulmonary Tuberculosis |
3.6% |
| Basal Cell Carcinoma |
3.0% |
| Lung Neoplasm Malignant |
2.7% |
| Lymphoma |
2.5% |
| Disseminated Tuberculosis |
2.2% |
| Sepsis |
2.0% |
| Congenital Anomaly |
1.8% |
| Infusion Related Reaction |
1.8% |
| Malignant Melanoma |
1.8% |
| Vomiting |
1.8% |
| Squamous Cell Carcinoma |
1.6% |
| Weight Decreased |
1.6% |
|
| Secondary |
| Crohn's Disease |
44.8% |
| Rheumatoid Arthritis |
10.0% |
| Colitis Ulcerative |
8.1% |
| Premedication |
7.0% |
| Psoriasis |
4.7% |
| Drug Use For Unknown Indication |
4.0% |
| Inflammatory Bowel Disease |
3.6% |
| Product Used For Unknown Indication |
3.4% |
| Prophylaxis |
2.0% |
| Ankylosing Spondylitis |
1.9% |
| Psoriatic Arthropathy |
1.8% |
| Juvenile Arthritis |
1.7% |
| Hypertension |
1.6% |
| Pustular Psoriasis |
1.0% |
| Behcet's Syndrome |
0.8% |
| Gastritis |
0.8% |
| Drug Exposure During Pregnancy |
0.7% |
| Chronic Obstructive Pulmonary Disease |
0.7% |
| Gastrointestinal Disorder Therapy |
0.7% |
| Takayasu's Arteritis |
0.6% |
|
| Squamous Cell Carcinoma |
10.4% |
| Pulmonary Tuberculosis |
9.7% |
| Colitis Ulcerative |
8.4% |
| Crohn's Disease |
6.6% |
| Pancreatitis |
6.3% |
| Lymphoma |
5.1% |
| Malignant Melanoma |
5.0% |
| Squamous Cell Carcinoma Of Skin |
5.0% |
| Respiratory Disorder Neonatal |
4.4% |
| Small Intestinal Obstruction |
4.3% |
| Liver Disorder |
4.3% |
| Bladder Transitional Cell Carcinoma |
3.9% |
| B-cell Lymphoma |
3.7% |
| Drug Exposure During Pregnancy |
3.7% |
| Cervical Dysplasia |
3.5% |
| Bile Duct Cancer |
3.4% |
| Psoriasis |
3.4% |
| Basal Cell Carcinoma |
3.1% |
| Viral Infection |
3.0% |
| Wound Infection |
2.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
22.4% |
| Rheumatoid Arthritis |
21.7% |
| Product Used For Unknown Indication |
16.5% |
| Crohn's Disease |
15.5% |
| Psoriasis |
6.2% |
| Colitis Ulcerative |
4.7% |
| Psoriatic Arthropathy |
1.7% |
| Hypertension |
1.3% |
| Prophylaxis |
1.3% |
| Prophylaxis Against Graft Versus Host Disease |
1.1% |
| Pain |
1.1% |
| Unevaluable Event |
1.1% |
| Ankylosing Spondylitis |
0.8% |
| Polychondritis |
0.8% |
| Osteoporosis |
0.7% |
| Vitamin Supplementation |
0.7% |
| Arthritis |
0.6% |
| Cutaneous Sarcoidosis |
0.6% |
| Inflammatory Bowel Disease |
0.6% |
| Pustular Psoriasis |
0.6% |
|
| Drug Ineffective |
10.9% |
| Vomiting |
7.8% |
| Crohn's Disease |
7.3% |
| Lupus-like Syndrome |
7.3% |
| Rash |
5.7% |
| Infection |
5.2% |
| Rheumatoid Arthritis |
5.2% |
| Pulmonary Fibrosis |
4.7% |
| Sepsis |
4.7% |
| Weight Decreased |
4.7% |
| Injection Site Pain |
4.2% |
| Pyrexia |
4.2% |
| Rectal Haemorrhage |
4.2% |
| Urticaria |
4.2% |
| Psoriasis |
3.6% |
| Tuberculosis |
3.6% |
| Diarrhoea |
3.1% |
| Hypopyon |
3.1% |
| Nausea |
3.1% |
| Pain |
3.1% |
|
| Interacting |
| Psoriasis |
51.1% |
| Crohn's Disease |
17.8% |
| Takayasu's Arteritis |
13.3% |
| Osteoporosis |
6.7% |
| Rheumatoid Arthritis |
6.7% |
| Arthritis |
4.4% |
|
| Acute Psychosis |
23.5% |
| Blood Magnesium Decreased |
23.5% |
| Renal Cancer |
11.8% |
| B-cell Lymphoma |
5.9% |
| Drug Interaction |
5.9% |
| Haemophilus Bacteraemia |
5.9% |
| Leukopenia |
5.9% |
| Pyelonephritis Acute |
5.9% |
| Septic Shock |
5.9% |
| Tooth Abscess |
5.9% |
|
